Nervous system: subclinical target of SARS-CoV-2 infection
Open Access
- 23 June 2020
- journal article
- letter
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 91 (9) , 1010-1012
Abstract
Neurofilament light chain (NfL) is the most abundant and soluble protein of the neuronal cytoskeleton and is released during axonal injury. An increase of cerebrospinal fluid (CSF) and serum levels of NfL has been demonstrated in patients with several inflammatory and degenerative neurological disorders of the nervous system, in correlation with clinical and radiological activity.1 Several clinical reports showed that patients with COVID-19 suffer from neurological symptoms including non-specific manifestations as headache, hyposmia, dysgeusia and altered consciousness.2 To date, the pathogenesis of the aforementioned symptoms and the role of inflammatory factors in the context of this severe systemic condition have not been elucidated. Different possible mechanisms of neuronal damage have been hypothesised, including direct viral nervous system invasion through hematogenous dissemination or neuronal retrograde dissemination and indirect injury mediated by inflammatory processes due to the cytokine storm.2 The aim of this study was to explore the nervous system involvement in patients with COVID-19 by evaluating the presence of neurological symptoms and measuring serum NfL levels as biomarker of axonal damage.Keywords
Funding Information
- Fondazione Cassa di Risparmio di Verona Vicenza Belluno e Ancona (ENACT)
This publication has 5 references indexed in Scilit:
- Neurologic Features in Severe SARS-CoV-2 InfectionNew England Journal of Medicine, 2020
- Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, ChinaJAMA Neurology, 2020
- Reference interval and preanalytical properties of serum neurofilament light chain in Scandinavian adultsScandinavian Journal of Clinical and Laboratory Investigation, 2020
- Serum and CSF neurofilament light chain levels in antibody-mediated encephalitisJournal of Neurology, 2019
- Neurofilaments as biomarkers in neurological disordersNature Reviews Neurology, 2018